SCIROCCHI, FABIO
 Distribuzione geografica
Continente #
EU - Europa 594
NA - Nord America 281
AS - Asia 238
SA - Sud America 13
AF - Africa 6
OC - Oceania 3
Totale 1.135
Nazione #
IT - Italia 436
US - Stati Uniti d'America 269
SG - Singapore 80
CN - Cina 66
IN - India 35
SE - Svezia 35
FI - Finlandia 27
DE - Germania 19
KR - Corea 17
BG - Bulgaria 13
AR - Argentina 12
FR - Francia 12
HK - Hong Kong 12
CA - Canada 10
ID - Indonesia 10
NL - Olanda 8
CH - Svizzera 6
GB - Regno Unito 6
RU - Federazione Russa 6
UA - Ucraina 6
IE - Irlanda 5
JP - Giappone 4
AT - Austria 3
AU - Australia 3
DK - Danimarca 3
ES - Italia 3
IR - Iran 3
PT - Portogallo 3
TW - Taiwan 3
ZA - Sudafrica 3
MA - Marocco 2
NO - Norvegia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CL - Cile 1
CU - Cuba 1
KH - Cambogia 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
TG - Togo 1
TH - Thailandia 1
TR - Turchia 1
Totale 1.135
Città #
Rome 214
Singapore 50
Milan 31
Helsinki 25
Santa Clara 24
New York 20
Ashburn 16
Chandler 16
Perugia 15
Sofia 13
Hyderabad 12
Jakarta 10
Salt Lake City 10
Fairfield 9
Indore 8
Los Angeles 8
Albano Laziale 7
Boardman 7
Hong Kong 7
Houston 7
Palermo 7
Boston 6
Latina 6
Montreal 6
Princeton 6
Cambridge 5
Dublin 5
Hangzhou 5
Philadelphia 5
Pomezia 5
San Isidro 5
Seattle 5
Shanghai 5
Turin 5
Wilmington 5
Beijing 4
Chicago 4
Florence 4
Goyang-si 4
Millbury 4
Reggio Calabria 4
Renens 4
Wuhan 4
Aachen 3
Ann Arbor 3
Bengaluru 3
Bremen 3
Chiesina Uzzanese 3
Dongjak-gu 3
Falkenstein 3
Germiston 3
Jena 3
Kolkata 3
Modena 3
Monte Grande 3
Moscow 3
Somerville 3
Taipei 3
Tokyo 3
Trento 3
Woodbridge 3
Amsterdam 2
Anguillara 2
Basel 2
Bologna 2
Boulogne Sur Mer 2
Brindisi 2
Brunoy 2
Buenos Aires 2
Cappelle sul Tavo 2
Cascina 2
Columbus 2
Dallas 2
Delhi 2
Ercolano 2
Guangzhou 2
Hojslev 2
Incheon 2
Innsbruck 2
Jacksonville 2
Ladispoli 2
Lappeenranta 2
Lawrence 2
Lisbon 2
Livorno 2
L’Aquila 2
Mapo-gu 2
Monza 2
Naples 2
Norwalk 2
Novara 2
Nuneaton 2
Oslo 2
Palma 2
Portici 2
Rizziconi 2
Roanoke 2
Roseto degli Abruzzi 2
Sacramento 2
San Diego 2
Totale 754
Nome #
Circulating CD137 + T cells correlate with improved response to anti-PD1 immunotherapy in cancer patients 156
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma 112
Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: relief from immunosuppression is associated with clinical response 101
The role of soluble LAG3 and soluble immune checkpoints profile in advanced head and neck cancer: a pilot study 74
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line 67
Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients 65
MGL lectin receptor and immunosuppression networks in glioblastoma 62
Circulating CD137+T cells as an immune biomarker for response to anti-PD1 immunotherapy in NSCLC patients 59
Macrophage galactose-like lectin mediated interactions: investigating immunosuppressive mechanisms in glioblastoma 53
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma 46
null 45
Treg/CD137+ T cell balance as a novel biomarker of survival in advanced non-addicted NSCLC patients treated with immunotherapy as first-line 38
Network analysis to unveil lectins-mediated immunosuppression in glioblastoma 37
Circulating immunosuppression correlates with worse clinical outcome in head and neck cancer patients undergoing immunotherapy treatment 36
Immunogenic cell death and immunomodulatory effects of cabozantinib 35
Soluble Immune checkpoints, gut metabolites and performance status as parameters of response to Nivolumab treatment in NSCLC patients 34
Circulating CD137+ T cell subsets and MDCSs as immune biomarkers for response to anti-PD1 immunotherapy in NSCLC patients 32
null 25
DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patients 24
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs 23
Immune receptor CD137 as a biomarker in solid tumors and potential immunotherapeutic target in glioblastoma 23
Circulating CD137+ T cell levels are correlated with response to Pembrolizumab treatment in advanced head and neck cancer patients 23
null 22
Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature 12
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients 11
Soluble PD-L1 as a prognostic factor for Immunotherapy treatment in solid tumors: systematic review and meta-analysis 8
Totale 1.223
Categoria #
all - tutte 4.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 23 1 3 0 0 0 2 0
2021/2022151 14 5 2 6 9 5 10 16 11 15 41 17
2022/2023220 26 16 16 18 21 19 13 18 10 25 11 27
2023/2024417 7 28 14 26 52 87 18 32 5 43 66 39
2024/2025406 77 56 77 66 61 69 0 0 0 0 0 0
Totale 1.223